Evaxion Biotech Q3 EPS $(0.27) Down From $(0.26) YoY
Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.27) per share. This is a 3.85 percent decrease over losses of $(0.26) per share from the same period last year.
Mid-Afternoon Market Update: Dow Surges 200 Points; Grid Dynamics Shares Spike Higher
Toward the end of trading Friday, the Dow traded up 0.57% to 36,331.86 while the NASDAQ rose 0.20% to 15,972.41. The S&P also rose, gaining 0.40% to 4,698.70.
Mid-Day Market Update: Gold Rises 1%; Deciphera Pharmaceuticals Shares Plummet
Midway through trading Friday, the Dow traded up 0.65% to 36,358.13 while the NASDAQ rose 0.48% to 16,016.51. The S&P also rose, gaining 0.58% to 4,707.33.
64 Stocks Moving In Friday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.
81 Biggest Movers From Yesterday
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday.
55 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday.